Vaxart, Inc. (VXRT) Return on equity 2016–2025
Vaxart, Inc. (VXRT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
18.6%FY2025 · since FY2016: -157.2% → 18.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.6% | +132.2 pp |
| FY2024 | -113.6% | +29.0 pp |
| FY2023 | -142.7% | -45.2 pp |
| FY2022 | -97.4% | -59.9 pp |
| FY2021 | -37.6% | -11.5 pp |
| FY2020 | -26.1% | +117.8 pp |
| FY2019 | -144.0% | +16.7 pp |
| FY2018 | -160.6% | — |
| FY2016 | -157.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice